Galectin Therapeutics Inc (NASDAQ:GALT)

During the Trading Day
3.36 -0.07 / -2.04%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
3.36 -0.0004 / -0.01%
 
Volume: 2.4K

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Galectin Therapeutics Inc have a median target of 16.00, with a high estimate of 16.00 and a low estimate of 16.00. The median estimate represents a +376.19% increase from the last price of 3.36.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Galectin Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.20
Sales
$0.00
Reporting Date
May 15

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -11.11%
 
 
 
 
 
 
Growthannually 2.56%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account